{"DataElement":{"publicId":"3876443","version":"1","preferredName":"PSA Failure Risk Factor Classification Category","preferredDefinition":"Classification to describe the relative risk of PSA failure in an individual, based on the D'Amico risk classification system which is a standard in prostate cancer treatment.","longName":"PSA_FAIL_RSK_FCT_CAT","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"3876373","version":"1","preferredName":"PSA Failure Risk Factor Classification","preferredDefinition":"A rise in the blood level of PSA (prostate-specific antigen) in prostate cancer patients after treatment with surgery or radiation. PSA failure may occur in patients who do not have symptoms. It may mean that the cancer has come back._A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"PSA_RSK_FACT_CLASS","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"3876370","version":"1","preferredName":"PSA Failure","preferredDefinition":"A rise in the blood level of PSA (prostate-specific antigen) in prostate cancer patients after treatment with surgery or radiation. PSA failure may occur in patients who do not have symptoms. It may mean that the cancer has come back.","longName":"C93229","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"PSA Failure","conceptCode":"C93229","definition":"An increase in serum prostate-specific antigen (PSA) levels following treatment for prostate cancer.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A8ADC6-CDBF-208D-E040-BB89AD432BC2","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"ONEDATA","dateModified":"2013-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3876371","version":"1","preferredName":"Risk Factor Classification","preferredDefinition":"Anything that increases a person's chance of developing a disease. Some examples of risk factors for cancer include a family history of cancer, use of tobacco products, certain foods, exposure to radiation or cancer-causing agents, and certain genetic alterations.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C17103:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Risk Factor","conceptCode":"C17103","definition":"Any aspect of an individual's life, behavior, an environmental exposure, or an inborn or inherited characteristic that increases the likelihood of a disease, condition or injury.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A8ADC6-CDD0-208D-E040-BB89AD432BC2","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"ONEDATA","dateModified":"2013-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A8ADC6-CDE1-208D-E040-BB89AD432BC2","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3876421","version":"1","preferredName":"PSA Failure Risk Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"PSA_FAIL_RSK_CAT","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"20","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"High risk","valueDescription":"Stage T2c or PSA > 20 ng/mL or Gleason score > or = 8","ValueMeaning":{"publicId":"3876439","version":"1","preferredName":"Stage T2c or PSA > 20 ng/mL or Gleason score > or = 8","longName":"3876439","preferredDefinition":"High risk of PSA failure with disease stage T2c or PSA > 20 ng/mL or Gleason score > or = 8","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A92FD2-A7A4-DE91-E040-BB89AD432606","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5A92FD2-A7BD-DE91-E040-BB89AD432606","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"ONEDATA","dateModified":"2013-09-05","deletedIndicator":"No"},{"value":"Intermediate risk","valueDescription":"Stage T2b or Gleason score 7 or PSA level > 10 and < or = 20 ng/mL","ValueMeaning":{"publicId":"3876440","version":"1","preferredName":"Stage T2b or Gleason score 7 or PSA level > 10 and < or = 20 ng/mL","longName":"3876440","preferredDefinition":"Intermediate risk of PSA failure with disease stage T2b or Gleason score 7 or PSA level > 10 and < or = 20 ng/mL","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A92FD2-A7C7-DE91-E040-BB89AD432606","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5A92FD2-A7E0-DE91-E040-BB89AD432606","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"ONEDATA","dateModified":"2013-09-05","deletedIndicator":"No"},{"value":"Low risk","valueDescription":"Stage T1c, T2a, and PSA levels < or = 10 ng/mL and Gleason score < or = 6","ValueMeaning":{"publicId":"3876441","version":"1","preferredName":"Stage T1c, T2a, and PSA levels < or = 10 ng/mL and Gleason score < or = 6","longName":"3876441","preferredDefinition":"Low risk of PSA failure with disease stage T1c, T2a, and PSA levels < or = 10 ng/mL and Gleason score < or = 6","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A92FD2-A7EA-DE91-E040-BB89AD432606","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5A92FD2-A803-DE91-E040-BB89AD432606","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"ONEDATA","dateModified":"2013-09-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"RTOG CRF:Radiation Therapy Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"E5A8347A-8207-747B-E040-BB89AD4312D0","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"REEVESD","dateModified":"2013-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"PSA Failure Risk","type":"Preferred Question Text","description":"PSA Failure Risk","url":null,"context":"CCR"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E5A92FD2-A835-DE91-E040-BB89AD432606","latestVersionIndicator":"Yes","beginDate":"2013-09-05","endDate":null,"createdBy":"REEVESD","dateCreated":"2013-09-05","modifiedBy":"REEVESD","dateModified":"2015-04-14","changeDescription":"Curated to support NCI CCR clinical trial","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}